The US Food and Drug Administration (FDA) has granted rare paediatric disease designation to Quoin Pharmaceuticals’ candidate in development for the treatment of Peeling Skin Syndrome (PSS), marking ...
The LSTM in the UK has opened a £20m ($23.2m) robotic AI laboratory to test drugs and vaccines against infections and diseases.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results